#523 Initial efficacy and safety results from ENGOT-Ov60/GOG-3052/RAMP 201: a phase 2 study of avutometinib (VS-6766) ± defactinib in recurrent low-grade serous ovarian cancer (LGSOC)
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Nicoletta Colombo Carol Aghajanian Susana Banerjee Rachel N. Grisham |
| Publication date | September 2023 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |